Literature DB >> 8381098

Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis.

C Féray1, M Gigou, D Samuel, G Reyes, J Bernuau, M Reynes, H Bismuth, C Bréchot.   

Abstract

BACKGROUND: The role of hepatitis C virus (HCV) in the development of fulminant hepatitis is poorly understood.
METHODS: The polymerase chain reaction was used to detect HCV RNA and hepatitis B virus (HBV) DNA in serum and liver of 40 patients with fulminant or subfulminant hepatitis.
RESULTS: HCV RNA was detected in none of the 23 subjects with hepatitis B surface antigen (HBsAg)-negative hepatitis of unknown etiology. HBV DNA was found in 1 of these 23 subjects. In contrast, 8 of the 17 patients with HBsAg-positive hepatitis were HCV RNA positive. Among the latter, 5 had immunoglobulin (Ig) M antibody to hepatitis B core antigen (anti-HBc) and thus were acutely coinfected by HBV and HCV, whereas 3 others without IgM anti-HBc had superinfection by HCV. The active replication of HCV in the liver was shown by detection of high titers of HCV RNA and of negative-stranded HCV RNA.
CONCLUSION: This investigation therefore shows no evidence of a role for HCV infection in sporadic cases of fulminant hepatitis without defined etiology. However, it suggests that HCV might be implicated in a significant number of patients with HBV-related fulminant hepatitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381098     DOI: 10.1016/0016-5085(93)90425-c

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  29 in total

1.  Viral superinfection in previously unrecognized chronic carriers of hepatitis B virus with superimposed acute fulminant versus nonfulminant hepatitis.

Authors:  C M Chu; C T Yeh; Y F Liaw
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

Review 2.  Nonhepatic manifestations and combined diseases in HCV infection.

Authors:  S J Hadziyannis
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 3.  The quasispecies of hepatitis C virus and the host immune response.

Authors:  P Farci; J Bukh; R H Purcell
Journal:  Springer Semin Immunopathol       Date:  1997

Review 4.  Hepatitis C virus: molecular biology and genetic variability.

Authors:  C Bréchot
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 5.  Childhood hepatitis.

Authors:  S K Yachha; B C Sharma
Journal:  Indian J Pediatr       Date:  1994 Nov-Dec       Impact factor: 1.967

Review 6.  Regulatory mechanisms of viral hepatitis B and C.

Authors:  G Waris; A Siddiqui
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

Review 7.  Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation.

Authors:  G M Woolf; L M Petrovic; S E Rojter; F G Villamil; L Makowka; L G Podesta; L S Sher; L Memsic; J M Vierling
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

8.  Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis.

Authors:  D Mutimer; J Shaw; J Neuberger; S Skidmore; B Martin; S Hubscher; P McMaster; E Elias
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

9.  Interferon and cyclosporin A in the treatment of fulminant viral hepatitis.

Authors:  M Yoshiba; K Sekiyama; K Inoue; R Fujita
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

10.  Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection.

Authors:  G N Dalekos; K Achenbach; D Christodoulou; G K Liapi; E K Zervou; D A Sideris; E V Tsianos
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.